As of Wednesday close, Insmed Incorporated’s (NASDAQ:INSM) stock was up $0.47, moving up 2.17 percent to $22.08. The average number of shares traded per day over the past five days has been 1,016,680 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.01 fall in that time frame. In the last twenty days, the average volume was 1,249,780, while in the previous 50 days, it was 1,081,216.
Since last month, INSM stock retreated -0.23%. Shares of the company fell to $20.94 on 08/03/23, the lowest level in the past month. A 52-week high of $25.64 was reached on 08/10/23 after having rallying from a 52-week low of $16.04. Since the beginning of this year, INSM’s stock price has risen by 10.51% or $2.10, and marked a new high 9 times. However, the stock has declined by -13.88% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
INSM stock investors should be aware that Insmed Incorporated (INSM) stock had its last reported insider trading activity 51 days ago on Jul 11. Smith Michael Alexander, the General Counsel, Senior VP of the company, disposed of 740 shares for $20.18 on Jul 11. It resulted in a $14,933 divestment by the insider. Adsett Roger sold 8,981 shares at an average price of $19.32 on Jun 13. The insider now owns 151,352 shares following the transaction. On Jun 13, Chief Medical Officer Flammer Martina M.D. sold 8,868 shares at $19.27 apiece. The transaction was valued at $170,886.
Financial Health
In the three months ended June 29, Insmed Incorporated’s quick ratio stood at 4.80, while its current ratio was 5.20, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 78.90% percent. Based on annual data, INSM earned $190.23 million in gross profit and brought in $245.36 million in revenue.
In Insmed Incorporated’s quarter-end financial report for June 29, it reported total debt of $1.14 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. INSM’s revenue rose 16.82% to $63.68 million during the quarter, while net income inched up to $78.41 million. While analysts expected Insmed Incorporated to report -$1.13 quarterly earnings, the actual figure was -$1.78 per share, beating the consensus estimate by -57.50%. During the quarter, the company generated -$230.27 million in EBITDA. The liabilities of Insmed Incorporated were 1.59 billion at the end of its most recent quarter ended June 29, and its total debt was $1.34 billion. The value of shareholders’ equity is $143.8 million.
Technical Picture
This quick technical analysis looks at Insmed Incorporated’s (INSM) price momentum. With a historical volatility rate of 20.95%, the RSI 9-day stood at 54.92% on 30 August.
With respect to its five-day moving average, the current Insmed Incorporated price is down by -0.05% percent or -$0.01. At present, INSM shares trade +1.42% above its 20-day simple moving average and +31.19% percent above its 100-day simple moving average. However, the stock is currently trading approximately +9.25% above its SMA50 and +13.99% above its SMA200.
Stochastic coefficient K was 31.60% and Stochastic coefficient D was 30.56%, while ATR was 0.70. Given the Stochastic reading of 49.15% for the 14-day period, the RSI (14) reading has been calculated as 54.92%. As of today, the MACD Oscillator reading stands at -0.07, while the 14-day reading stands at -0.25.
